F.D.A. to Relabel Leucovorin for Autism TreatmentThe F.D.A. announced Monday that it would change the drug's label to reflect potential benefits in reducing autism symptoms.
Source: F.D.A. to Relabel Leucovorin for Autism Treatment (https://www.nytimes.com/2025/09/22/well/leucovorin-autism-fda.html)